GILEAD SCIENCES, INC. SG&A Expense 2007-2025 | GILD
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is GILEAD SCIENCES, INC.'s current sg&a expense?
GILEAD SCIENCES, INC. (GILD) annual sg&a expense for 2024 was $6.09B, a 0.02% increase from 2023. GILEAD SCIENCES, INC. sg&a expense for the quarter ending September 30, 2025 was $1.36B.
What was GILEAD SCIENCES, INC.'s sg&a expense in 2023?
GILEAD SCIENCES, INC. annual sg&a expense for 2023 was $6.09B, a 7.35% increase from 2022.
What was GILEAD SCIENCES, INC.'s sg&a expense in 2022?
GILEAD SCIENCES, INC. annual sg&a expense for 2022 was $5.67B, a 8.14% increase from 2021.
What is GILEAD SCIENCES, INC.'s 5-year sg&a expense CAGR?
GILEAD SCIENCES, INC. sg&a expense grew at a compound annual growth rate (CAGR) of 6.81% from FY2019 to FY2024, going from $4.38B to $6.09B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+6.8%
FY2019
$4.38B
→
FY2024
$6.09B
070809101112131415161718192021222324
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $6.09B | +0.0% | 10-K |
| FY2023 | $6.09B | +7.4% | 10-K |
| FY2022 | $5.67B | +8.1% | 10-K |
| FY2021 | $5.25B | +1.8% | 10-K |
| FY2020 | $5.15B | +17.6% | 10-K |
| FY2019 | $4.38B | +8.0% | 10-K |
| FY2018 | $4.06B | +4.6% | 10-K |
| FY2017 | $3.88B | +14.1% | 10-K |
| FY2016 | $3.40B | -0.8% | 10-K |
| FY2015 | $3.43B | +14.9% | 10-K |
| FY2014 | $2.98B | +75.6% | 10-K |
| FY2013 | $1.70B | +16.3% | 10-K |
| FY2012 | $1.46B | +17.6% | 10-K |
| FY2011 | $1.24B | +18.9% | 10-K |
| FY2010 | $1.04B | +10.3% | 10-K |
| FY2009 | $946.7M | +18.7% | 10-K |
| FY2008 | $797.3M | +13.0% | 10-K |
| FY2007 | $705.7M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →